Rajani Associates advises Beaufond Industries on Resolution Plan for Kobo Biotech
Rajani Associates advised Beaufond Industries Limited, the Successful Resolution Applicant, in relation to the resolution plan of Kobo Biotech Limited. The resolution plan, valued at approximately ₹70 crore, was submitted to the Committee of Creditors on March 4, 2026, approved by the Committee of Creditors on March 17, 2026, and subsequently approved by the National Company Law Tribunal on May 11, 2026. As part of the resolution process, Rajani Associates advised on the resolution plan and the composite scheme of amalgamation and arrangement. The approved resolution plan provides for the merger of Beaufond Industries with Kobo…
SectorPharma & Healthcare
Value₹70 cr
Sources
Open in the live tracker →Related deals
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Trilegal acts on Berry Street - Healthify merger27 Aug 2026
- ChrysCapital-backed KIMS in talks to acquire minority stake in Renova Hospitals for $52M25-26 Aug 2026 · $52 million
- Mankind Pharma Limited: Other Restructuring26 Aug 2026
- Mankind Pharma Limited: Outcome of Board Meeting26 Aug 2026